Identification of novel driver risk genes in CNV loci associated with neurodevelopmental disorders
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Azidane, Sara
- dc.contributor.author Gallego, Xavier
- dc.contributor.author Durham, Lynn
- dc.contributor.author Cáceres Aguilar, Mario
- dc.contributor.author Guney, Emre
- dc.contributor.author Pérez-Cano, Laura
- dc.date.accessioned 2025-06-02T06:22:39Z
- dc.date.available 2025-06-02T06:22:39Z
- dc.date.issued 2024
- dc.description.abstract Copy-number variants (CNVs) are genome-wide structural variations involving the duplication or deletion of large nucleotide sequences. While these types of variations can be commonly found in humans, large and rare CNVs are known to contribute to the development of various neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD). Nevertheless, given that these NDD-risk CNVs cover broad regions of the genome, it is particularly challenging to pinpoint the critical gene(s) responsible for the manifestation of the phenotype. In this study, we performed a meta-analysis of CNV data from 11,614 affected individuals with NDDs and 4,031 control individuals from SFARI database to identify 41 NDD-risk CNV loci, including 24 novel regions. We also found evidence for dosage-sensitive genes within these regions being significantly enriched for known NDD-risk genes and pathways. In addition, a significant proportion of these genes was found to (1) converge in protein-protein interaction networks, (2) be among most expressed genes in the brain across all developmental stages, and (3) be hit by deletions that are significantly over-transmitted to individuals with ASD within multiplex ASD families from the iHART cohort. Finally, we conducted a burden analysis using 4,281 NDD cases from Decipher and iHART cohorts, and 2,504 neurotypical control individuals from 1000 Genomes and iHART, which resulted in the validation of the association of 162 dosage-sensitive genes driving risk for NDDs, including 22 novel NDD-risk genes. Importantly, most NDD-risk CNV loci entail multiple NDD-risk genes in agreement with a polygenic model associated with the majority of NDD cases.
- dc.format.mimetype application/pdf
- dc.identifier.citation Azidane S, Gallego X, Durham L, Cáceres M, Guney E, Pérez-Cano L. Identification of novel driver risk genes in CNV loci associated with neurodevelopmental disorders. HGG Adv. 2024 Jul 18;5(3):100316. DOI: 10.1016/j.xhgg.2024.100316
- dc.identifier.doi http://dx.doi.org/10.1016/j.xhgg.2024.100316
- dc.identifier.issn 2666-2477
- dc.identifier.uri http://hdl.handle.net/10230/70584
- dc.language.iso eng
- dc.publisher Elsevier
- dc.relation.ispartof HGG Adv. 2024 Jul 18;5(3):100316
- dc.rights © 2024 The Authors. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.rights.uri http://creativecommons.org/licenses/by/4.0/
- dc.subject.keyword Copy number variants
- dc.subject.keyword Decipher database
- dc.subject.keyword SFARI database
- dc.subject.keyword Autism spectrum disorder
- dc.subject.keyword Burden testing
- dc.subject.keyword Dosage-sensitive genes
- dc.subject.keyword iHART cohort
- dc.subject.keyword Neurodevelopmental disorders
- dc.subject.keyword Risk genes and pathways
- dc.subject.keyword Structural variants
- dc.title Identification of novel driver risk genes in CNV loci associated with neurodevelopmental disorders
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/publishedVersion